VOLITIONRX LTD — Director's Dealing 2020

Feb 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-02-26

Reporting Person: TERRELL JASON BRADLEY MD (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-26	Warrant (Right to Buy)	$2.47	A	125000	Acquired	2023-02-26	Common Stock (125000)	Direct

Footnotes

F1: The vesting criteria of the one remaining installment of a Warrant originally granted to the reporting person on March 20, 2013, as amended, was deemed met pursuant to approval of the Compensation Committee of the Issuer effective February 26, 2020, resulting in vesting of the Warrant as to 125,000 shares effective February 26, 2020. The vested shares shall expire three years after the vesting date.